CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Alivus Life Sciences Ltd.

NSE : ALIVUSEQ BSE : 543322 ISIN CODE : INE03Q201024Industry : Pharmaceuticals

News

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 06 Mar 2026 | 16:56 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of Analyst/Institutional Investor meetingsmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 06 Mar 2026 | 16:54 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...

  • Alivus Life Sciences - Updates 25 Feb 2026 | 19:52 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange regarding Disclosure under Regulation 30 of SEBI LODR .more...

  • Alivus Life Sciences - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And 25 Feb 2026 | 19:48 | Dion Global

    Kindly refer attachment.more...

  • Alivus Life Sciences - General Updates 16 Feb 2026 | 11:44 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about General Updatesmore...

  • Alivus Life Sciences - Announcement Under Regulation 30 - Updates 16 Feb 2026 | 11:44 | Dion Global

    Kindly refer the enclosed attachment.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 02 Feb 2026 | 17:27 | Dion Global

    Kindly refer enclosed attachment.more...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 02 Feb 2026 | 17:23 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of meetmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 30 Jan 2026 | 18:45 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Transcript of Earnings Callmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 30 Jan 2026 | 18:43 | Dion Global

    Please find enclosed herewith transcript of Earnings Call held on 22nd January 2026 which is also made available on the website of the Company.more...

  • Alivus Life Sciences - General Updates 30 Jan 2026 | 17:41 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about General Updatesmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 28 Jan 2026 | 14:48 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of Analyst/Institutional Investor meetings.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 28 Jan 2026 | 14:44 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 22 Jan 2026 | 20:04 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Link of Recording of Earnings Callmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 22 Jan 2026 | 20:00 | Dion Global

    Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ...more...

  • Alivus Life Sciences Q3 net profit up 9.71% at Rs 150.26 cr 22 Jan 2026 | 15:20 | Dion Global

    The company reported standalone net profit of Rs 150.26 crore for the quarter ended December 31 2025 as compared to Rs 136.96 crore in the s...more...

  • Alivus Life Sciences - Investor Presentation 22 Jan 2026 | 14:31 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Investor Presentationmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation 22 Jan 2026 | 14:28 | Dion Global

    Please find enclosed herewith Investors Presentation - Q3 FY 25-26.more...

  • Alivus Life Sciences - Press Release 22 Jan 2026 | 14:23 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange regarding a press release dated January 22 2026 titled Press Release on Unaudited Financial Re...more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release 22 Jan 2026 | 14:22 | Dion Global

    Enclosed please find herewith the Press Release on Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended De...more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex76034.42-1.08%
B500DIVL503547.840.81%
BSE 1000 10166.66-0.65%
BSE 100LCTMC8807.93-0.82%
BSE Auto 55697.6-2.92%
BSE BasicMat7891.34-0.13%

Commodity

Gold159809-0.21%
Silver2686010.96%
Copper1235.1202.87%
Crude Oil802125.07%
Lead197.647.02%
Mentha Oil1063.9-0.33%
Nickel1635.5113.26%

Currency

USD/INR 92.26(0.62 %)
GBP/INR 122.91(0.34 %)
EUR/INR 106.59(0.16 %)
JPY/INR 0.58(-0.13 %)
CAD/INR 67.91(0.56 %)
HKD/INR 11.80(0.67 %)